-
ABOUT USSSY Group Limited is a large high-tech pharmaceutical enterprise with coordinated development of R&D and industrialization in multiple fields such as new drugs, generic drugs, characteristic APIs
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the development mode of “production, learning, research, and application” of multi-disciplinary integration and multi-directional combination.
-
RECRUITIt has established high-level innovation platforms such as engineering laboratory and technology research center jointly with Chinese Academy of Sciences, and now has nearly 400 high-level talents in drug research, analysis and clinical research.
-
SUBSIDIARIESThe company has a diversified business development pattern of R&D, production and export of new drugs, generic drugs, characteristic APIs, advanced finished pharmaceutical products, biological preparations and pharmaceutical packaging materials.
-
CONTACTWe will continue to strengthen innovation-driven development, will vigorously encourage the integration of production and research, strengthen and improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs
Shijiazhuang Sihua Pharmaceutical Group Has Been Awarded Numerous Honors, Including Top Ten Enterprises in the Provincial Pharmaceutical Industry
Category:
发布时间：2024-08-10
【概要描述】
At the Second Session of the Fourth Council of the Hebei Provincial Pharmaceutical Industry Association held on August 9, lists were announced including the Top Ten Pharmaceutical Enterprises in Hebei Province for 2023, the Most Promising Pharmaceutical Enterprises in Hebei Province for 2023, the Top Ten Pharmaceutical Distribution Enterprises in Hebei Province for 2023, and the 2024 Science and Technology Awards.
At the Second Session of the Fourth Council of the Hebei Provincial Pharmaceutical Industry Association held on August 9, lists were announced including the Top Ten Pharmaceutical Enterprises in Hebei Province for 2023, the Most Promising Pharmaceutical Enterprises in Hebei Province for 2023, the Top Ten Pharmaceutical Distribution Enterprises in Hebei Province for 2023, and the 2024 Science and Technology Awards.
Shijiazhuang Sihua Pharmaceutical Group was honored as one of the Top Ten Pharmaceutical Enterprises in Hebei Province for 2023. Two projects—“Key Technological Development and Industrial Application of Pentoxifylline Injection” and “Key Technological Development and Industrial Application of Terbutaline Sulfate Solution for Nebulization”—were awarded the First Prize for Scientific and Technological Progress. Meanwhile, two projects from the Group’s subsidiaries—Guangxiang Pharmaceutical’s “Research and Application of Key Process Catalysts for Xanthine-Based Active Pharmaceutical Ingredients” and Guolong Pharmaceutical’s “Key Technological Development and Industrial Application of Dexmedetomidine Hydrochloride API”—each received the Second Prize for Scientific and Technological Progress.
In recent years, the Group has taken it as its mission to “research, develop, and produce more ‘Chinese medicines’ that are tailored to the genetic heritage and physical characteristics of the Chinese population,” staying true to its original aspiration of “making quality medicines for the people.” Adhering to the “Four Orientations,” the Group has relentlessly pursued innovation with a dynamic, forward-looking approach, strengthened talent support, and actively fostered and developed new, innovation-driven productive forces. Through continuous product iteration and breakthroughs built on solid foundations, the Group has maintained industry-leading R&D quality and efficiency, steadily unlocking new momentum and competitive advantages. At the same time, by leveraging the construction of smart manufacturing workshops as a key driver, the Group has accelerated its digital transformation and the advancement of new industrialization, significantly enhancing the efficiency of research-to-market translation. This has effectively empowered the optimization and refinement of the company’s supply structure, promoted high-quality, efficient scale-up, and elevated the Group’s influence and competitiveness in the industry to new heights.
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Address: Shimen Building, No. 8 Xingye Street, Shijiazhuang Economic and Technological Development Zone
Tel.: +86-311-67167130
Email: office@sjzsiyao.com
Mobile site
E code
Non-Commercial (Filing) – 2025-0091